Global Liquid Biopsy Technology Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Liquid Biopsy Technology Market Insights, Forecast to 2034
Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating tumor DNA or ctDNA) present in body fluids, primarily blood, to detect and monitor various diseases, especially cancer. Unlike traditional biopsies that involve invasive procedures to collect tissue samples, liquid biopsy offers a less invasive and potentially more convenient method for disease detection and monitoring.
Market Analysis and InsightsGlobal Liquid Biopsy Technology Market
Global Liquid Biopsy Technology market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Liquid Biopsy Technology industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
Report Covers
This report presents an overview of global Liquid Biopsy Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Liquid Biopsy Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Segment by Type
CTCs
ctDNA
Exosomes
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Liquid Biopsy Technology introduction, etc. Liquid Biopsy Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Liquid Biopsy Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Liquid Biopsy Technology Market
Global Liquid Biopsy Technology market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Liquid Biopsy Technology industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
Report Covers
This report presents an overview of global Liquid Biopsy Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Liquid Biopsy Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Segment by Type
CTCs
ctDNA
Exosomes
Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Liquid Biopsy Technology introduction, etc. Liquid Biopsy Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Liquid Biopsy Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch